Nabriva Therapeutics PLC (NASDAQ:NBRV)

0.181
Delayed Data
As of Jun 30
 -0.024 / -11.71%
Today’s Change
0.17
Today|||52-Week Range
1.40
-69.78%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Schroeder Theodore R
Chief Executive Officer
Buy12/28/2021100,000$0.57$57.0K-67.76%
Schroeder Theodore R
Chief Executive Officer
Buy9/14/202150,000$1.13$56.5K-83.30%
Schroeder Theodore R
Chief Executive Officer
Sale1/29/202210,766$0.45$4.8K-62.32%
Naftzger John Christopher
Secretary & General Counsel
Buy12/27/20217,000$0.59$4.1K-68.18%
Gelone Steven P
President & Chief Operating Officer
Sale1/29/20223,483$0.45$1.6K-62.32%
Burgess Daniel D
Director
Sale8/02/20211,125$1.20$1.4K-84.29%
Bourdow Carrie L
Director
Sale8/02/2021777$1.20$932.40-84.29%
Rowland Charles A Jr
Director
Sale8/02/2021777$1.20$932.40-84.29%
Webster Stephen W
Director
Sale8/02/2021777$1.20$932.40-84.29%
Broom Colin
Director
Sale8/02/2021531$1.20$637.20-84.29%
Page of 7